Suven Pharmaceuticals Limited has informed the Exchange about Intimation of Effective Date of merger and Record Date
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.1 pts less than Nifty Smallcap 250 and 1.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Suven Pharmaceuticals has informed the exchange about the effective date and record date for its merger with Cohance Lifesciences. This indicates that the merger scheme has received all required approvals, including NCLT clearance, and is now moving into execution. Shareholders on the record date will be eligible to receive shares in the merged entity as per the approved swap ratio. The announcement marks a key milestone in the corporate restructuring between the two listed entities.
Shareholders should note the record date to determine entitlement in the merged entity. The stock may see short-term volatility around the effective date as investors adjust holdings for the share swap.